{"GHMDC classification":["Treatment"],"GHMDC health topic":["Child mortality"],"GHMDC manufacturer coordinates":["15.926666666667, 107.96508611111"],"GHMDC manufacturer location":["Vietnam"],"GHMDC scope":["Commercialized"],"Page SDG":["SDG09 Industry innovation and infrastructure","SDG03 Good health and well-being"],"Page URL":["https://www.appropedia.org/Global_Health_Medical_Device_Compendium/Bilibed"],"Page affiliations":["Appropedia Foundation","University of Michigan"],"Page authors":["User:Lonny","User:Chriswaterguy","User:Emilio","Kathleen Sienko","Amir Sabet Sarvestani"],"Page description":["Sixty percent of all newborns develop some form of jaundice after birth, and about twelve percent of these newborns need to receive immediate treatment for severe jaundice. If left untreated, severe jaundice can cause life-threatening brain damage. Although this condition can be treated with phototherapy, this treatment method is currently too expensive to be used in low-resource health facilities."],"Page image":["File:Bilibed2.png"],"Page language":["en"],"Page license":["CC-BY-SA-3.0"],"Page parent":["Global Health Medical Device Compendium"],"Page root":["Global Health Medical Device Compendium"],"Page title":["Global Health Medical Device Compendium/Bilibed"],"Page views":[207],"Page year":["Tuesday, 01-Jan-13 00:00:00 UTC"],"Modification date":["Thursday, 10-Sep-26 14:05:21 UTC"]}